Correlation Between Hansa Biopharma and Xbrane Biopharma
Can any of the company-specific risk be diversified away by investing in both Hansa Biopharma and Xbrane Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hansa Biopharma and Xbrane Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hansa Biopharma AB and Xbrane Biopharma AB, you can compare the effects of market volatilities on Hansa Biopharma and Xbrane Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hansa Biopharma with a short position of Xbrane Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hansa Biopharma and Xbrane Biopharma.
Diversification Opportunities for Hansa Biopharma and Xbrane Biopharma
-0.7 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Hansa and Xbrane is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Hansa Biopharma AB and Xbrane Biopharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xbrane Biopharma and Hansa Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hansa Biopharma AB are associated (or correlated) with Xbrane Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xbrane Biopharma has no effect on the direction of Hansa Biopharma i.e., Hansa Biopharma and Xbrane Biopharma go up and down completely randomly.
Pair Corralation between Hansa Biopharma and Xbrane Biopharma
Assuming the 90 days trading horizon Hansa Biopharma AB is expected to generate 0.34 times more return on investment than Xbrane Biopharma. However, Hansa Biopharma AB is 2.93 times less risky than Xbrane Biopharma. It trades about -0.01 of its potential returns per unit of risk. Xbrane Biopharma AB is currently generating about -0.02 per unit of risk. If you would invest 5,650 in Hansa Biopharma AB on August 26, 2024 and sell it today you would lose (2,582) from holding Hansa Biopharma AB or give up 45.7% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Hansa Biopharma AB vs. Xbrane Biopharma AB
Performance |
| Timeline |
| Hansa Biopharma AB |
| Xbrane Biopharma |
Hansa Biopharma and Xbrane Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hansa Biopharma and Xbrane Biopharma
The main advantage of trading using opposite Hansa Biopharma and Xbrane Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hansa Biopharma position performs unexpectedly, Xbrane Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xbrane Biopharma will offset losses from the drop in Xbrane Biopharma's long position.| Hansa Biopharma vs. Bavarian Nordic | Hansa Biopharma vs. BioPorto | Hansa Biopharma vs. Zaptec AS | Hansa Biopharma vs. cBrain AS |
| Xbrane Biopharma vs. Hansa Biopharma AB | Xbrane Biopharma vs. Vicore Pharma Holding | Xbrane Biopharma vs. XSpray Pharma AB | Xbrane Biopharma vs. Saniona AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |